Ian is a Senior Project Manager in the Global Engineering group for Catalent’s Biomodalities division, overseeing capital project implementation and operational startup across various cell and gene therapy facilities in the US and Europe. His 10 years’ experience in the pharmaceutical CDMO industry include roles held in API, small molecule, cell therapy, and gene therapy manufacturing facilities and process development laboratories. He has detailed experience in fill & finish operations, as well as strategic Capex planning and implementation. Ian holds a B.S. Chemical Engineering from the University of Pittsburgh, and an MBA from Villanova School of Business.